Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:515 (3 September), doi:10.1136/bmj.331.7515.515-b
| The first 150 words of the full text of this article appear below. |
EDITORI agree with Maxwell that evidence based prescribing is complex and requires clinical experience, common sense, and some knowledge of clinical pharmacology.1 The drugs that I can prescribe are governed primarily by a strict hospital formulary and, in some cases, the primary care trust formulary. The formulary often has a limited number of drugs (often only one) that can be prescribed for each class, and the choice is often determined not by evidence but cost per tablet (and not even longer term cost effectiveness). This kind of restriction is often defended by policy-makers using the "class effect" argument. The hospital's necessity to slash the drug budget has led to some good drugs being excluded from the formulary, despite their use being supported by class A evidence and national clinical guidelines.
As clinicians, we are encouraged to practice evidence based medicine, and many of us spend hours every week
Joseph Kwan, specialist registrar in geriatric medicine
Elderly Care Research Unit, Southampton General Hospital, Southampton SO16 6YD jk@1to1.org
Read all Rapid Responses